N-环己基-Β-苯胺 | 26872-84-4

• 物质功能分类: 生物化工 - 多肽
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: N-环己基-Β-苯胺
• 英文名称: N-cyclohexyl-3-aminopropionic acid
• 英文别名: β-cyclohexylaminopropionic acid；3-N-cyclohexylaminopropionic acid；N-cyclohexyl-β-alanine；N-cyclohexyl-β-alanine；N-Cyclohexyl-β-alanin；3-cyclohexylaminopropionic acid；3-(Cyclohexylazaniumyl)propanoate
• CAS: 26872-84-4
• 化学式: C₉H₁₇NO₂
• mdl: MFCD00021328
• 分子量: 171.239
• InChiKey: ATFRXUJCSMOJPH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.6
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.888
• 拓扑面积：
  49.3
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2922499990

SDS

---

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : N-Cyclohexyl-Beta-Alanine
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Acute toxicity, Oral (Category 4), H302
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Xn Harmful R22
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Warning
Hazard statement(s)
H302 Harmful if swallowed.
Precautionary statement(s) none
Supplemental Hazard none
Statements
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

---

SECTION 3: Composition/information on ingredients
Substances
Molecular weight : 0 g/mol
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
N-Cyclohexyl-Beta-Alanine
Acute Tox. 4; H302 <= 100 %
Hazardous ingredients according to Directive 1999/45/EC
Component Classification Concentration
N-Cyclohexyl-Beta-Alanine
Xn, R22 <= 100 %
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

---

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
No data available

---

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Nature of decomposition products not known.
Advice for firefighters
Wear self-contained breathing apparatus for firefighting if necessary.
Further information
No data available

---

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Storage class (TRGS 510): Non Combustible Solids
Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

---

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

---

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour No data available
c) Odour Threshold No data available
d) pH No data available
e) Melting point/freezing No data available
point
f) Initial boiling point and No data available
boiling range
g) Flash point No data available
h) Evaporation rate No data available
i) Flammability (solid, gas) No data available
j) Upper/lower No data available
flammability or
explosive limits
k) Vapour pressure No data available
l) Vapour density No data available
m) Relative density No data available
n) Water solubility No data available
o) Partition coefficient: n- No data available
octanol/water
p) Auto-ignition No data available
temperature
q) Decomposition No data available
temperature
r) Viscosity No data available
s) Explosive properties No data available
t) Oxidizing properties No data available
Other safety information
No data available

---

SECTION 10: Stability and reactivity
Reactivity
No data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
No data available
Conditions to avoid
No data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
In the event of fire: see section 5

---

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
No data available
Skin corrosion/irritation
No data available
Serious eye damage/eye irritation
No data available
Respiratory or skin sensitisation
No data available
Germ cell mutagenicity
No data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
No data available
Specific target organ toxicity - single exposure
No data available
Specific target organ toxicity - repeated exposure
No data available
Aspiration hazard
No data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

---

SECTION 12: Ecological information
Toxicity
No data available
Persistence and degradability
No data available
Bioaccumulative potential
No data available
Mobility in soil
No data available
Results of PBT and vPvB assessment
This substance/mixture contains no components considered to be either persistent, bioaccumulative and
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
Other adverse effects
No data available

---

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

SECTION 14: Transport information
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
No data available

---

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
No data available
Chemical Safety Assessment
For this product a chemical safety assessment was not carried out

---

SECTION 16: Other information
Full text of H-Statements referred to under sections 2 and 3.
Acute Tox. Acute toxicity
H302 Harmful if swallowed.
Full text of R-phrases referred to under sections 2 and 3
Xn Harmful
R22 Harmful if swallowed.
Further information
Copyright 2014 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

反应信息

• 作为反应物：
  描述：

  N-环己基-Β-苯胺 在 磷酸 、 水 、 三氯化磷 作用下， 生成 1-hydroxy-3-cyclohexylaminopropylidenediphosphonic acid
  参考文献：
  名称：

  NewN-substituted 1-hydroxy-3-aminopropylidenediphosphonic acids

  摘要：

  N-Substituted 1-hydroxy-3-aminopropylidenediphosphonic acids were synthesized. Their acid-base and complexation properties toward a wide series of metal cations in water were investigated.

  DOI：

  10.1007/bf02495695
• 作为产物：
  描述：

  3-(环己基氨基)丙酸乙酯 在 sodium hydroxide 、 水 作用下， 以 四氢呋喃 为溶剂， 反应 1.0h， 以64%的产率得到N-环己基-Β-苯胺
  参考文献：
  名称：

  WRINKLE-IMPROVING AGENT

  摘要：

  该发明提供了一种新型的改善皱纹的剂，具有改善皱纹的效果，即使应用于皮肤也不会带来安全或疼痛问题，并且包含一种非常安全的物质作为活性成分。发现N-苯甲酰-β-丙氨酸、其他特定的β-丙氨酸衍生物及其盐具有改善皱纹的效果，因此开发了一种改善皱纹的剂，其活性成分包含从这些特定的β-丙氨酸衍生物及其盐组成的群体中选择的一种、两种或更多种化合物。

  公开号：

  EP1941861A1

文献信息

• [EN] POLO-LIKE KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASE DE TYPE POLO
  申请人：TAKEDA PHARMACEUTICAL

  公开号：WO2009067547A1

  公开（公告）日：2009-05-28

  Compounds of the following formula are provided for use with kinases, wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.

  提供以下公式的化合物供激酶使用，其中变量如本文所定义。还提供包含这些化合物的药物组合物、试剂盒和制造物品；用于制备这些化合物的方法和中间体；以及使用这些化合物的方法。
• Parakeratosis inhibitor, pore -shrinking agent and external compositon for skin
  申请人：Kaminuma Mikiko

  公开号：US20120232111A1

  公开（公告）日：2012-09-13

  The invention provides a parakeratosis inhibitor, pore-shrinking agent, or rough skin preventing/ameliorating agent that has a function such as parakeratosis inhibition, pore shrinkage, or rough skin—inhibition/abatement, poses no safety problems such as sensory irritation, and is very safe, and further provides an external composition for skin to which a compound having the above-mentioned function has been added. The parakeratosis inhibitor, pore-shrinking agent, or rough skin preventing/ameliorating agent comprises one or more compounds selected from the group consisting of β-alanine derivatives and salts thereof. The external composition for skin comprises the one or more compounds selected from the group consisting of β-alanine derivatives and salts thereof as the above-mentioned parakeratosis inhibitor, pore-shrinking agent, or rough skin preventing/ameliorating agent.

  本发明提供了一种角化过度抑制剂、毛孔收缩剂或粗糙肌肤预防/改善剂，具有诸如角化过度抑制、毛孔收缩或粗糙肌肤抑制/减轻等功能，不会引起感觉刺激等安全问题，非常安全，还提供了一种外用皮肤组成物，其中添加了具有上述功能的化合物。该角化过度抑制剂、毛孔收缩剂或粗糙肌肤预防/改善剂包括从β-丙氨酸衍生物和其盐的群组中选择的一种或多种化合物。该外用皮肤组成物包括上述β-丙氨酸衍生物和其盐中的一种或多种作为上述角化过度抑制剂、毛孔收缩剂或粗糙肌肤预防/改善剂。
• Kupplungsmittel zwischen mineralischen Füllstoffen und Polymeren
  申请人：Plüss-Staufer AG

  公开号：EP0154811A2

  公开（公告）日：1985-09-18

  Es werden neue Kupplungsmittel zwischen mineralischen Füllstoffen, insbesondere CaC03 einerseits und Polymeren andererseits, Zwischenprodukte zur Herstellung dieser Kupplungsmittel, Verfahren zur Herstellung dieser Kupplungsmittel, Verfahren zur Herstellung der genannten Zwischenprodukte, mineralische Füllstoffe und Verfahren zur Herstellung dieser mineralischen Füllstoffe offenbart. Die neuen Kupplungsmittel sind gekennzeichnet durch die allgemeine Formel Y-R-X, worin Y eine oder mehrere Säuregruppen oder deren Alkali-oder Erdalkali-salz(e), Y eine oder mehrere reaktive Gruppen aus der Klasse der organischen Azide als Nitrenquelle und R ein chemisches Verbindungsstück zwischen den beiden reaktiven Gruppen X und Y in Form eines aliphatischen und/oder olefinischen und/oder aromatischen Zwischenstücks mit 2-40 C-Atomen bedeuten. Besonders günstige Eigenschaften weisen die Kupplungsmittel aus der Gruppe der Azidosulfonyl-carbonsäuren mit der allgemeinen Formel N3S02-A-Z-B-COOH auf, wobei A,B - aliphatische und/oder aromatische Reste mit jeweils 2-18 C-Atomen und Z - 0, S, N bedeuten.

  本发明公开了矿物填料（尤其是 CaC03）与聚合物之间的新型偶联剂、制备这些偶联剂的中间体、制备这些偶联剂的工艺、制备上述中间体的工艺、矿物填料以及制备这些矿物填料的工艺。新型偶联剂的通式为 Y-R-X，其中 Y 为一个或多个酸基或碱金属或碱土金属盐，Y 为一个或多个作为腈源的有机叠氮化物类活性基团，R 为两个活性基团 X 和 Y 之间的化学连接，其形式为具有 2-40 个碳原子的脂肪族和/或烯烃族和/或芳香族中间体。通式为 N3S02-A-Z-B-COOH 的叠氮磺酰基羧酸类偶联剂具有特别有利的特性，其中 A、B 分别为具有 2-18 个碳原子的脂肪族和/或芳香族基，Z 为 0、S、N。
• PARAKERATOSIS INHIBITOR, PORE-SHRINKING AGENT AND EXTERNAL COMPOSITION FOR SKIN
  申请人：Shiseido Company, Limited

  公开号：EP1880711A1

  公开（公告）日：2008-01-23

  The invention provides a parakeratosis inhibitor, pore-shrinking agent, or rough skin preventing/amaliorating agent that has a function such as parakeratosis inhibition, pore shrinkage, or rough skin -inhibition/abatement, poses no safety problems such as sensory irritation, and is very safe, and further provides an external composition for skin to which a compound having the above-mentioned function has been added. The parakeratosis inhibitor, pore-shrinking agent, or rough skin preventing/amaliorating agent comprises one or more compounds selected from the group consisting of β-alanine derivatives and salts thereof. The external composition for skin comprises the one or more compounds selected from the group consisting of β-alanine derivatives and salts thereof as the above-mentioned parakeratosis inhibitor, pore-shrinking agent, or rough skin preventing/amaliorating agent.

  本发明提供了一种角化抑制剂、毛孔收缩剂或皮肤粗糙预防/改善剂，它具有抑制角化、收缩毛孔或皮肤粗糙抑制/改善等功能，不会造成感官刺激等安全问题，而且非常安全，并进一步提供了一种添加了具有上述功能的化合物的皮肤外用组合物。角化抑制剂、毛孔收缩剂或皮肤粗糙预防/改善剂包括一种或多种选自 β-丙氨酸衍生物及其盐类的化合物。皮肤外用组合物包括选自由 β-丙氨酸衍生物及其盐组成的组的一种或多种化合物，作为上述角化病抑制剂、毛孔收缩剂或皮肤粗糙预防/改善剂。
• Chlorine-resistant polyethylene compound and articles made therefrom
  申请人：Fina Technology, Inc.

  公开号：US10584823B2

  公开（公告）日：2020-03-10

  A method includes transporting water containing chlorine dioxide, chlorine, chloramines, or hypochlorites through a pipe. The method includes forming a polyethylene resin using a catalyst, mixing the polyethylene resin with an antioxidant, wherein the antioxidant is a thioester, a hindered amine light stabilizer or 1,3,5-trimethyl-2,4,6-tris (3,5-di-tert-butyl-4-hydroxybenzyl) benzene to form a resin/antioxidant mixture, extruding pipe from the resin/antioxidant mixture, and flowing water containing chlorine dioxide, chlorine, chloramines, or hypochlorites through the pipe. An extruded article is adapted for use in containment and/or transport of water that contains chlorine dioxide, chlorine, chloramines, or hypochlorites. The extruded article includes a polyethylene resin and an antioxidant. The antioxidant is a thioester, a hindered amine light stabilizer or 1,3,5-trimethyl-2,4,6-tris (3,5-di-tert-butyl-4-hydroxybenzyl) benzene.

  一种方法包括通过管道输送含有二氧化氯、氯、氯胺或次氯酸盐的水。该方法包括使用催化剂形成聚乙烯树脂，将聚乙烯树脂与抗氧化剂混合，其中抗氧化剂为硫酯、受阻胺光稳定剂或 1，3，5-三甲基-2，4，6-三（3、5-二叔丁基-4-羟基苄基）苯形成树脂/抗氧化剂混合物，用树脂/抗氧化剂混合物挤出管材，并使含有二氧化氯、氯、氯胺或次氯酸盐的水流过管材。挤压制品适用于封闭和/或运输含有二氧化氯、氯、氯胺或次氯酸盐的水。挤压制品包括聚乙烯树脂和抗氧化剂。抗氧化剂是硫酯、受阻胺光稳定剂或 1,3,5-三甲基-2,4,6-三（3,5-二叔丁基-4-羟基苄基）苯。